Genexine, Foreign Investors Net Sell 1,000 Shares... Stock Price Down 3.64%
Genexine ranked among the top searched stocks for 13 days in the past month.
As of 12:31 PM on the 31st, Genexine is trading at 179,500 KRW, up 3.64% from the previous day. This represents a 52.12% increase compared to August 12. Genexine is known as a company specializing in the development of biopharmaceuticals.
Today, foreigners are tentatively recorded as net sellers of 1,000 shares of Genexine, and institutions are net sellers of 3,000 shares. Over the past five days, individual investors have net bought 431,378 shares, while foreigners and institutions have net sold 40,138 shares and 105,301 shares, respectively.
On August 27, Genexine became a market issue with the news of confirming the efficacy of 'Interleukin-7' in treating COVID-19, rising 17.7%.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
